Cargando…
The SMARCA4(R1157W) mutation facilitates chromatin remodeling and confers PRMT1/SMARCA4 inhibitors sensitivity in colorectal cancer
Genomic studies have demonstrated a high frequency of genetic alterations in components of the SWI/SNF complex including the core subunit SMARCA4. However, the mechanisms of tumorigenesis driven by SMARCA4 mutations, particularly in colorectal cancer (CRC), remain largely unknown. In this study, we...
Autores principales: | Zeng, Xiangwei, Yao, Bing, Liu, Jianpeng, Gong, Guan-Wen, Liu, Ming, Li, Jiahuang, Pan, Hua-Feng, Li, Qixiang, Yang, Dongjun, Lu, Peifen, Wu, Dongliang, Xu, Peipei, Chen, Bing, Chen, Panhai, Zhang, Ming, Zen, Ke, Jing, Jian, Huang, David C. S., Chen, Dijun, Jiang, Zhi-Wei, Zhao, Quan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10017700/ https://www.ncbi.nlm.nih.gov/pubmed/36922568 http://dx.doi.org/10.1038/s41698-023-00367-y |
Ejemplares similares
-
PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling
por: Yao, Bing, et al.
Publicado: (2021) -
Correction to: PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling
por: Yao, Bing, et al.
Publicado: (2021) -
Analysis of SMARCA4 and SMARCA2 Loss in Lung Sarcomatoid Carcinomas
por: Urer, Halide Nur, et al.
Publicado: (2023) -
Selective PROTAC-mediated degradation of SMARCA2 is efficacious in SMARCA4 mutant cancers
por: Cantley, Jennifer, et al.
Publicado: (2022) -
High expression of SMARCA4 or SMARCA2 is frequently associated with an opposite prognosis in cancer
por: Guerrero-Martínez, Jose A., et al.
Publicado: (2018)